Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-29

Clinical Trial Update: Investigation of GLP1-Receptor Agonists in Men With Prostate Cancer Taking Androgen Deprivation Therapy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is investigating GLP-1 receptor agonists in men with prostate cancer who are receiving androgen deprivation therapy; recruitment is ong…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GLP-1 receptor agonists

Snippet

Sponsor: Hamilton Health Sciences Corporation | Conditions: Prostate Cancer | Phase 4 | Status: RECRUITING